Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature

Bibliographic Details
Main Authors: Nawaf Almutairi, Bayoumy Eassa
Format: Article
Language:English
Published: Termedia Publishing House 2020-01-01
Series:Advances in Dermatology and Allergology
Subjects:
Online Access:https://www.termedia.pl/Comparing-the-efficacy-and-safety-of-IL-17-inhibitors-for-treatment-of-moderate-to-severe-psoriasis-a-randomized-double-blind-pilot-study-with-a-review-of-literature,7,39535,1,1.html
id doaj-c3e2da34ba714940afac2b307043e25a
record_format Article
spelling doaj-c3e2da34ba714940afac2b307043e25a2021-10-06T07:58:58ZengTermedia Publishing HouseAdvances in Dermatology and Allergology1642-395X2299-00462020-01-0138228128810.5114/ada.2019.9149639535Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literatureNawaf AlmutairiBayoumy Eassahttps://www.termedia.pl/Comparing-the-efficacy-and-safety-of-IL-17-inhibitors-for-treatment-of-moderate-to-severe-psoriasis-a-randomized-double-blind-pilot-study-with-a-review-of-literature,7,39535,1,1.htmlplaque psoriasis il-17 inhibitors secukinumab ixekizumab
collection DOAJ
language English
format Article
sources DOAJ
author Nawaf Almutairi
Bayoumy Eassa
spellingShingle Nawaf Almutairi
Bayoumy Eassa
Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
Advances in Dermatology and Allergology
plaque psoriasis
il-17 inhibitors
secukinumab
ixekizumab
author_facet Nawaf Almutairi
Bayoumy Eassa
author_sort Nawaf Almutairi
title Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
title_short Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
title_full Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
title_fullStr Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
title_full_unstemmed Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
title_sort comparing the efficacy and safety of il-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature
publisher Termedia Publishing House
series Advances in Dermatology and Allergology
issn 1642-395X
2299-0046
publishDate 2020-01-01
topic plaque psoriasis
il-17 inhibitors
secukinumab
ixekizumab
url https://www.termedia.pl/Comparing-the-efficacy-and-safety-of-IL-17-inhibitors-for-treatment-of-moderate-to-severe-psoriasis-a-randomized-double-blind-pilot-study-with-a-review-of-literature,7,39535,1,1.html
work_keys_str_mv AT nawafalmutairi comparingtheefficacyandsafetyofil17inhibitorsfortreatmentofmoderatetoseverepsoriasisarandomizeddoubleblindpilotstudywithareviewofliterature
AT bayoumyeassa comparingtheefficacyandsafetyofil17inhibitorsfortreatmentofmoderatetoseverepsoriasisarandomizeddoubleblindpilotstudywithareviewofliterature
_version_ 1716841182861983744